SEC Form 4 · accession 0000899243-16-011359
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Schembri
Officer — See Remarks
Period of report
Aug 17, 2015
Accepted (ET)
Jan 7, 2016 · 9:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | P | 500 | $20.00 | A | 500 | D | |
| Common Stock | Jan 7, 2016 | P | 1,000 | $22.36 | A | 1,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Vice President, Finance and Administration and Corporate Secretary